The structural characterisation of the semaglutide highlights the presence of an Aib substitution at position 8, limiting degradation by DPP-4, and the attachment of a lipid chain favouring binding to albumin
Individual outcomes depend on multiple factors including adherence to treatment protocols, starting weight, metabolic health, lifestyle modifications, and other variables unique to each person
Some athletes report struggling to eat adequate meals on GLP-1 medications, which could potentially hinder muscle protein synthesis if protein intake falls too low
Now, I should probably know the exact mechanism differences off the top of my head, but let me think about this properly
Consistency in timing and dosage is crucial for optimal results